Search clinical trials for: Thrombotic microangiopathy

Total 802 results

Alexandria University

Completed

Comparison Between Unihemispheric and Bihemispheric TCDS in Subacute Ischemic Stroke Patients

Hemiplegia | Spasticity, Muscle | Stroke, Ischemic | Stroke, Acute | Motor Activity | Hemiparesis | Stroke, Lacunar | Spastic | Hemiplegic Gait

Egypt
Synchron Medical, Inc.

Withdrawn

SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

Paralysis | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Neurologic Disorder | Spinal Muscular Atrophy | Spinal Cord Injury | Stroke, Lacunar | Upper Limb Injury | Paralysis; Stroke | Stroke, Brainstem

Australia
ARCA Biopharma, Inc.
Colorado Prevention Center

Completed

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 (ASPEN)

Covid19

United States, Argentina, Brazil
Damascus University
Unipharma, HamaPharma, Almujtahed hospital

Completed

Rivaroxaban vs. Warfarin in CVT Treatment (RWCVT)

Cerebral Vein Thrombosis

Syrian Arab Republic
Amsterdam UMC, location VUmc

Completed

Thrombotic Complications After Central Venous Catheterization (TARZAN)

Central Venous Catheter Thrombosis

Netherlands
Straub Medical AG

Completed

PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

Arteriovenous Graft Thrombosis

Czechia
Hutchison Medipharma Limited

Active, not recruiting

Phase III Study on HMPL-523 for Treatment of ITP

Primary Immune Thrombocytopenia (ITP)

China
Association des Médecins Vasculaires Hospitaliers
Sanofi; Ministry of Health, France; Daiichi Sankyo, Inc.; LEO Pharma; University...

Completed

Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) (SPOT)

Cardiovascular Diseases | Venous Thromboembolism | Post Thrombotic Syndrome

France
Baylor College of Medicine

Active, not recruiting

Post IVIG Medication in Children With Immune Thrombocytopenia

Immune Thrombocytopenia

United States
University Hospital, Ghent

Completed

Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease

Atypical Hemolytic Uraemic Syndrome

Belgium
Sanofi

Completed

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

Immune-mediated Thrombocytopenic Purpura

France
University of British Columbia

Terminated

Virtual Reality, Mood, and Sedentary Behaviour After Stroke

Stroke | Stroke, Ischemic | Stroke Hemorrhagic | Stroke, Lacunar

Canada
Shire
Takeda Development Center Americas, Inc.

Completed

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) (SOAR-HI)

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

United States, Spain, Canada, United Kingdom, France, Germany, Italy
Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Primary Immune Thrombocytopenia

China
Amgen

Completed

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenic Purpura
Amgen

Completed

P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura

Idiopathic Thrombocytopenic Purpura
Amgen

Completed

Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenic Purpura
Amgen

Completed

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura
Amgen

Completed

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura
Groupe Hospitalier Paris Saint Joseph

Terminated

Study of the Interest of Patients Undergoing Anti-thrombotic Treatment in a Digital Application of Therapeutic Assistance (APPLIAC)

Vascular Diseases

France
University of Copenhagen
Herlev Hospital

Completed

Effect of Remote Ischemic Conditioning on Vascular Health in Stroke Patients (VISP)

Stroke, Lacunar

Denmark
University Hospitals Bristol and Weston NHS Foundation...
Cardiff University

Completed

Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate (FLIGHT)

Immune Thrombocytopenia

United Kingdom
SK Plasma Co., Ltd.

Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Korea, Republic of
Hospital Civil de Guadalajara

Completed

Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine

Primary Immune Thrombocytopenia

Mexico
Amgen

Completed

Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

Thrombocytopenia | Idiopathic Thrombocytopenic Purpura
Amgen

Completed

Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim

Idiopathic Thrombocytopenic Purpura

Italy, United States, Germany, Czechia, United Kingdom, Australia, Spain, Poland, France
Herlev Hospital
University of Copenhagen; Association of Danish Physiotherapists

Active, not recruiting

The Effect of Aerobic Exercise in Patients With Lacunar Stroke (HITPALS)

Stroke, Lacunar

Denmark
University of Edinburgh
University of Nottingham; British Heart Foundation

Completed

LACunar Intervention (LACI-2) Trial-2 (LACI-2)

Cerebral Small Vessel Diseases | Stroke, Lacunar

United Kingdom
Fujian Medical University Union Hospital

Enrolling by invitation

Optimization of Glucocorticoid Taper Strategies for SLE-ITP

Lupus Erythematosus, Systemic | Purpura, Thrombocytopenic, Idiopathic | Glucocorticoids | Adverse Effect of Glucocorticoids

China
AO GENERIUM

Completed

Observational Study of Elizaria® in aHUS Patients

Atypical Hemolytic Uremic Syndrome | aHUS

Russian Federation
Jiangsu HengRui Medicine Co., Ltd.

Completed

Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient

Idiopathic Thrombocytopenic Purpura

China
Daiichi Sankyo, Inc.

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease

United States, Spain, Canada, Lebanon, Turkey, Austria, Croatia, Egypt, France, Hungary, India, Israel, Ukraine, United Kingdom
University of Surrey

Completed

Macro- and Microvascular Response to Cocoa Flavanols in Healthy and Type 2 Diabetes

Healthy Participants | Arterial Stiffness | Vascular Endothelium | Microangiopathy, Diabetic | Polyphenol | Optical Tomography

United Kingdom
Novartis Pharmaceuticals

Completed

Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea.

Polycythemia Vera (PV)

United States
Amgen

Completed

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

United States, Canada, Belgium, Czechia, Mexico, Turkey, Australia, Spain, France, Israel, Hungary, South Africa, Poland, Russian Federation, United Kingdom, Brazil, Switzerland
University of Alberta

Withdrawn

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack (MENA-TIA)

Transient Ischemic Attacks | Minor Stroke

Canada
Medical College of Wisconsin
Ohio State University; Versiti

Completed

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Neoplasms | Venous Thrombosis

United States
University Hospital, Caen

Completed

Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause. (LOCAPORT)

Portal Vein Thrombosis | Local Cause

France
Sanofi

Completed

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Thrombotic Thrombocytopenic Purpura

Japan
Sanofi

Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Austria, Belgium, Canada, Czechia, France, Hungary, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom
Rambam Health Care Campus

Completed

The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.

Atrial Fibrillation | Thrombosis Cardiac | Left Atrial Thrombosis

Israel
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Multimodal Retinal Imaging of Cerebrovascular Stroke (OCTAV)

Stroke | Cerebrovascular Accidents

France
ID3 Medical

Completed

Belgian Trial Evaluating the ClearLumen II Peripheral Thrombectomy System Recanalization of (Sub)Acute Thrombotic Femoropopliteal Occlusions (BELTHROM)

Peripheral Arterial Disease

Belgium
Nantes University Hospital

Completed

Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT (SYMPATHIC)

Idiopathic Thrombocytopenic Purpura

France
PharmaDiall Ltd.

Completed

Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19

COVID-19 | Venous Thromboembolism

Russian Federation
Institute of Liver and Biliary Sciences, India

Completed

To Compare "Balloon Occluded Thrombolysis" With "Conventional Catheter Directed Thrombolysis" in Thrombotically Occluded DIPSS Stent in Patients of Budd- Chiari Syndrome.

Budd-Chiari Syndrome

India
VA Office of Research and Development
University of Maryland, College Park

Completed

Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome (EFFORT2)

Acute Deep Vein Thrombosis

United States
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care (MAGMAT)

Thrombotic Thrombocytopenic Purpura

France
Nayera Hazaa Elsherif

Completed

The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.

Idiopathic Thrombocytopenic Purpura

Egypt
Ming Hou

Completed

The Serum Lipid Profiles in ITP: a Retrospective Study

Immune Thrombocytopenia

China

Search clinical trials for: Thrombotic microangiopathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations